Breaking News: After U.S. FDA Clearance, Ordinatrum Receives Saudi FDA (SFDA) Clearance for Arc System!

Blog - 06-20-2025 07:00

We’re excited to announce that Ordinatrum has now received Saudi Food and Drug Authority (SFDA) clearance for our Arc System, following our FDA 510(k) clearance in the United States.

This dual regulatory milestone reflects the growing global recognition of our commitment to innovation, safety, and excellence in critical care.

With SFDA clearance, we’re proud to expand our reach and support the Kingdom of Saudi Arabia’s healthcare transformation journey—delivering advanced, intelligent care solutions where they’re needed most.

A heartfelt thank you to our dedicated team, global partners, and expert advisors. Your support continues to fuel our mission.

The future is exciting!